Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count

Saved in:
Bibliographic Details
Main Authors: Rocío del Campo-Pedrosa, Alfonso Martín-Carnicero, Ana González-Marcos, Alfredo Martínez
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2024.1540165/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841527611883257856
author Rocío del Campo-Pedrosa
Rocío del Campo-Pedrosa
Alfonso Martín-Carnicero
Ana González-Marcos
Alfredo Martínez
author_facet Rocío del Campo-Pedrosa
Rocío del Campo-Pedrosa
Alfonso Martín-Carnicero
Ana González-Marcos
Alfredo Martínez
author_sort Rocío del Campo-Pedrosa
collection DOAJ
format Article
id doaj-art-7212d3dc5c534183bff7d3ca52f69d49
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-7212d3dc5c534183bff7d3ca52f69d492025-01-15T11:47:09ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011410.3389/fonc.2024.15401651540165Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte countRocío del Campo-Pedrosa0Rocío del Campo-Pedrosa1Alfonso Martín-Carnicero2Ana González-Marcos3Alfredo Martínez4Data Department, Encore Lab S.L., Logroño, SpainDepartment of Mechanical Engineering, Universidad de La Rioja, Logroño, SpainMedical Oncology Department, Hospital San Pedro, Logroño, SpainDepartment of Mechanical Engineering, Universidad de La Rioja, Logroño, SpainAngiogenesis Group, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spainhttps://www.frontiersin.org/articles/10.3389/fonc.2024.1540165/fullprognosis modelprognostic biomarkersoverall survivalgamma glutamyl transferase (GGT)lactate dehydrogenase (LDH)advanced and metastatic pancreatic cancer
spellingShingle Rocío del Campo-Pedrosa
Rocío del Campo-Pedrosa
Alfonso Martín-Carnicero
Ana González-Marcos
Alfredo Martínez
Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
Frontiers in Oncology
prognosis model
prognostic biomarkers
overall survival
gamma glutamyl transferase (GGT)
lactate dehydrogenase (LDH)
advanced and metastatic pancreatic cancer
title Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
title_full Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
title_fullStr Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
title_full_unstemmed Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
title_short Corrigendum: New model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring GGT and LDH levels and monocyte count
title_sort corrigendum new model to predict survival in advanced pancreatic ductal adenocarcinoma patients by measuring ggt and ldh levels and monocyte count
topic prognosis model
prognostic biomarkers
overall survival
gamma glutamyl transferase (GGT)
lactate dehydrogenase (LDH)
advanced and metastatic pancreatic cancer
url https://www.frontiersin.org/articles/10.3389/fonc.2024.1540165/full
work_keys_str_mv AT rociodelcampopedrosa corrigendumnewmodeltopredictsurvivalinadvancedpancreaticductaladenocarcinomapatientsbymeasuringggtandldhlevelsandmonocytecount
AT rociodelcampopedrosa corrigendumnewmodeltopredictsurvivalinadvancedpancreaticductaladenocarcinomapatientsbymeasuringggtandldhlevelsandmonocytecount
AT alfonsomartincarnicero corrigendumnewmodeltopredictsurvivalinadvancedpancreaticductaladenocarcinomapatientsbymeasuringggtandldhlevelsandmonocytecount
AT anagonzalezmarcos corrigendumnewmodeltopredictsurvivalinadvancedpancreaticductaladenocarcinomapatientsbymeasuringggtandldhlevelsandmonocytecount
AT alfredomartinez corrigendumnewmodeltopredictsurvivalinadvancedpancreaticductaladenocarcinomapatientsbymeasuringggtandldhlevelsandmonocytecount